Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Charles N Landen
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
110 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ctca at Western Regional Medical Center
Goodyear, Arizona, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Danbury Hospital
Danbury, Connecticut, United States
- Norwalk Hospital
Norwalk, Connecticut, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Helen F Graham Cancer Center
Newark, Delaware, United States
- Beebe Health Campus
Rehoboth Beach, Delaware, United States
- Sarasota Memorial Hospital
Sarasota, Florida, United States
- Northside Hospital
Atlanta, Georgia, United States
- Augusta University Medical Center
Augusta, Georgia, United States
- Lewis Cancer and Research Pavilion at Saint Joseph'S/candler
Savannah, Georgia, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- Summit Cancer Care-Candler
Savannah, Georgia, United States
- John H Stroger Jr Hospital of Cook County
Chicago, Illinois, United States
- Northwestern University
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Carle at the Riverfront
Danville, Illinois, United States
- Carle Physician Group-Effingham
Effingham, Illinois, United States
- Northwestern Medicine Lake Forest Hospital
Lake Forest, Illinois, United States
- Carle Physician Group-Mattoon/charleston
Mattoon, Illinois, United States
- Uc Comprehensive Cancer Center at Silver Cross
New Lenox, Illinois, United States
- University of Chicago Medicine-Orland Park
Orland Park, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- the Carle Foundation Hospital
Urbana, Illinois, United States
- Midwestern Regional Medical Center
Zion, Illinois, United States
- Parkview Regional Medical Center
Fort Wayne, Indiana, United States
- Ascension Saint Vincent Indianapolis Hospital
Indianapolis, Indiana, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Norton Hospital Pavilion and Medical Campus
Louisville, Kentucky, United States
- Norton Suburban Hospital and Medical Campus
Louisville, Kentucky, United States
- Mary Bird Perkins Cancer Center
Baton Rouge, Louisiana, United States
- Woman'S Hospital
Baton Rouge, Louisiana, United States
- Women'S Cancer Care-Covington
Covington, Louisiana, United States
- Ochsner Medical Center Jefferson
New Orleans, Louisiana, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Umass Memorial Medical Center - Memorial Division
Worcester, Massachusetts, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Nov 2016
- Primary completion
- 30 Sept 2021
- Completion
- 22 May 2024
- Last update posted
- 25 May 2025
- Registered enrollment
- 147
- Registry id
- NCT02713386
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.